Cargando…
Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo
SIMPLE SUMMARY: Glycolysis is one of the hallmarks of cancer. Therefore, the development of novel therapeutical strategies for colorectal cancer targeting glycolysis may improve treatment responses. PFKFB3 expression has been directly associated with enhanced glycolysis, not only in cancer cells but...
Autores principales: | De Oliveira, Tiago, Goldhardt, Tina, Edelmann, Marcus, Rogge, Torben, Rauch, Karsten, Kyuchukov, Nikola Dobrinov, Menck, Kerstin, Bleckmann, Annalen, Kalucka, Joanna, Khan, Shawez, Gaedcke, Jochen, Haubrock, Martin, Beissbarth, Tim, Bohnenberger, Hanibal, Planque, Mélanie, Fendt, Sarah-Maria, Ackermann, Lutz, Ghadimi, Michael, Conradi, Lena-Christin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957803/ https://www.ncbi.nlm.nih.gov/pubmed/33671096 http://dx.doi.org/10.3390/cancers13051011 |
Ejemplares similares
-
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution
por: Fleischer, Johannes Robert, et al.
Publicado: (2023) -
High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome
por: Menck, Kerstin, et al.
Publicado: (2022) -
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019) -
Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines
por: Wlochowitz, Darius, et al.
Publicado: (2016) -
Ran kan kan /
por: Puente, Tito, 1923-2000
Publicado: (2008)